Effects of Crimomycin Combined with Moxifloxacin Intrathoracic Injection on the Serum and Pleural Effusion Interferon-γ TNF-α CEA and ADA Levels of Patients with Tuberculous Pleurisy
TAO Guanyu, et al
Dazhou Integrated Traditional Chinese and Western Medicine Hospital, Sichuan Dazhou 635000, China
Abstract：Objective: To research the effect of crimomycin combined moxifloxacin intrathoracic injection on the serum and pleural effusion interferon-γ(IFN-γ), tumor necrosis factor-α(TNF-α), carcinoembryonic antigen (CEA), adenosine deaminase (ADA) levels of patients with tuberculous pleurisy. Methods: 98 cases of patients with tuberculous pleurisy admitted to our hospital from April 2013 to April 2016 were selected and randomly divided into two groups, the control group was treated with crimomycin, while the experimental group was treated with moxifloxacin based on the control group. The clinical curative effect, changes of serum and pleural effusion IFN-γ, TNF-α, CEA, ADA, forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), pleural thickness levels before and after treatment and incidence of adverse reactions were compared between two groups. Results: The total effective rate of experimental group was higher than that of the control group (P<0.05). Serum and pleural effusion IFN-γ, FVC and FEV1 in two groups were significantly higher than those before treatment, and the above indexes were significantly higher in the experimental group than in the control group. Serum TNF- α, CEA, ADA and pleural thickness in two groups were significantly lower than before treatment, and the above indexes were significantly lower than those in the control group. There were statistically significant differences in the interactions between the two groups, between different time points, between groups, and between different time points (P<0.05). There was no statistically significant difference between the two groups (P>0. 05). Conclusion: The curative effect of crimomycin combined moxifloxacin intrathoracic injection was bettetr than monocolomycin alone with tuberculous pleurisy patients in the treatment of patients with tuberculous pleurisy, whcih can effectively regulate the serum and pleural effusion levels of interferon-γ, TNF-α, CEA, ADA.
陶冠宇, 杨仁旭, 任焱, 熊浪, 刘南伶. 卷曲霉素联合莫西沙星胸腔注射对结核性胸膜炎患者血清和胸腔积液IFN-γ TNF-α CEA ADA水平的影响[J]. 河北医学, 2018, 24(6): 898-901.
TAO Guanyu, et al. Effects of Crimomycin Combined with Moxifloxacin Intrathoracic Injection on the Serum and Pleural Effusion Interferon-γ TNF-α CEA and ADA Levels of Patients with Tuberculous Pleurisy. HeBei Med, 2018, 24(6): 898-901.
2018, Vol. 24 
冀公网安备13080202000677号